A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR 1202 alone in Patients with Previously Treated Non-Hodgkin’s Lymphoma

Sponsor
TG Therapeutics

Protocol Number
UTX-TGR-205

To Learn More Call
201-510-0910